Why Does Aspirin Cause Tinnitus? And Is It Reversible?

Uncover the science behind aspirin-induced tinnitus, exploring its causes, influencing factors, and whether this auditory effect is reversible.

Aspirin causes tinnitus because its active breakdown product, salicylate, disrupts the mechanical and electrical activity of the inner ear at multiple levels, from the tiny motor proteins inside sensory cells to the nerve signals traveling up to the brain. The ringing is typically described as high-pitched and emerges at moderate to high doses. For most people, it fades within a day or two of stopping the drug. But the story is more layered than “aspirin irritates your ears,” because salicylate simultaneously changes how the brain processes sound, which helps explain why the phantom noise can feel so loud and intrusive even when the hearing loss itself is mild.

What Salicylate Does Inside the Ear

Your inner ear contains rows of outer hair cells whose job is to amplify incoming sound vibrations. They do this through a protein called prestin, which sits in the cell membrane and rapidly changes shape in response to electrical signals, physically lengthening and shortening the cell thousands of times per second. Salicylate binds directly to prestin by slipping into the same slot that chloride ions normally occupy. This locks prestin in a stuck, halfway state so it can no longer flex properly.

The result is a dose-dependent loss of that amplification. In isolated outer hair cells from guinea pig cochleae, salicylate concentrations as low as 0.05 millimolar produced visible changes in cell shape and motility, with the effect scaling up as the dose increased.

Because prestin-driven motility is what fine-tunes the ear’s sensitivity and frequency selectivity, blocking it degrades hearing and, critically, changes the pattern of signals the brain receives. That altered signal appears to be one trigger for the phantom sound.

Nerve Cells in the Cochlea Get Overexcited

Disrupting the outer hair cells is only half the picture. Salicylate also changes how the nerve cells (spiral ganglion neurons) that carry sound information to the brain respond to their chemical messenger, glutamate. In particular, aspirin selectively amplifies the response of one type of glutamate receptor, the NMDA subtype, while leaving other glutamate receptor types relatively untouched.

NMDA receptors are involved in excitatory signaling. When salicylate boosts their activity, it increases the calcium flooding into those neurons and ramps up their firing rate beyond normal levels.

Think of it like turning up the gain on a microphone that is already receiving a distorted signal from the outer hair cells. The cochlear nerve starts sending excessive, abnormal activity to the brain, and the brain interprets some of that hyperactivity as sound. This neural excitation at the periphery feeds directly into the central changes described below.

The Brain Turns Up Its Own Volume

Perhaps the most important piece of the puzzle is what happens further upstream. Salicylate does not just affect the ear; it crosses into the brain and changes how auditory processing centers handle incoming signals. In the auditory cortex, salicylate reduces inhibitory signaling carried by GABA, the brain’s main “calm down” neurotransmitter. Recordings from rat auditory cortex neurons showed that salicylate depressed inhibitory currents in a concentration-dependent way, reducing them to roughly 60% of normal at higher concentrations.

With GABA-mediated inhibition weakened, auditory neurons become more excitable. The brain effectively turns up the gain on its own sound-processing circuitry. Researchers demonstrated this by giving salicylate to rats under anesthesia with isoflurane, a drug that boosts GABA activity. Under those conditions, the salicylate-induced increase in auditory cortex responses vanished, confirming that the gain increase depended on reducing GABA inhibition.

This central gain increase is a big deal because it means tinnitus from aspirin is not purely an ear problem. Even if the ear’s damage is subtle, the brain amplifies whatever abnormal signals it receives, making the phantom ringing louder and more intrusive than you might expect from the modest hearing loss salicylate typically produces. Work on the inferior colliculus, a relay station between the ear and the cortex, suggests that salicylate also disrupts inhibitory neurons there, potentially creating hyperactivity at multiple stops along the auditory pathway.

Blood Supply to the Inner Ear Takes a Hit Too

The cochlea has a specialized blood supply system called the stria vascularis, which maintains the chemical environment the hair cells need to function. Tiny blood vessel cells called pericytes help regulate blood flow there. Aspirin inhibits potassium channels in these pericytes in a dose-dependent fashion, with a half-maximal inhibitory concentration of about 25 micromoles per liter.

When pericyte potassium channels are suppressed, blood flow regulation in the stria vascularis is compromised. This can reduce the delivery of nutrients and oxygen to the hair cells and alter the ionic balance of the fluid that bathes them. While this vascular effect probably plays a secondary role compared to the direct prestin blockade and neural excitability changes, it adds another layer of stress to an already disrupted system. In a sense, aspirin hits the cochlea from several directions at once: mechanical, neural, and vascular.

What Aspirin-Induced Tinnitus Sounds Like

People who develop tinnitus from aspirin almost always describe a high-pitched ringing or hissing. Research clarifies why. Salicylate causes the greatest reductions in ear function at low frequencies (below about 10 kHz) and at very high frequencies (above about 20 kHz), while mid-range frequencies between 10 and 20 kHz are relatively spared.

The tinnitus pitch that people and animals match to the sound in their heads corresponds to that mid-frequency range, roughly where the ear is still working but receiving distorted input. That pattern is consistent with the theory that tinnitus arises where the brain detects a mismatch between what it expects to hear and what the compromised ear is actually sending. In addition, neurons in the auditory cortex and the lateral amygdala (an emotional-processing area) shift their preferred frequencies toward that mid-range band after salicylate exposure, rearranging the brain’s tonal map in a way that reinforces the phantom sound at those pitches.

Is the Tinnitus Reversible?

For the vast majority of people who develop tinnitus from aspirin, the answer is yes. Once you stop taking aspirin or reduce your dose, the tinnitus and any associated hearing loss typically resolve within 24 to 72 hours. The key mechanism behind this recovery is that salicylate’s binding to prestin is reversible: as blood levels of salicylate drop, the drug releases from prestin’s binding site, and the outer hair cells regain their normal motility.

The same reversibility has been confirmed at a functional level. Salicylate-induced changes in outer hair cell shape, motility, and overall cochlear mechanics return to baseline after the drug clears.

The central nervous system changes, like the increased gain and reduced GABA inhibition, also appear to normalize once the drug is gone, though the brain’s recovery timeline can lag slightly behind the ear’s.

There are circumstances that make the picture less clear-cut. Very high doses sustained over long periods create a more complicated situation. Chronic salicylate exposure causes the cochlea to compensate by ramping up its production of prestin protein and temporarily enhancing certain measures of ear function, almost as if the system is trying to fight back against the drug’s suppressive effects.

While even these chronic changes appear to be reversible in animal studies, the long-term data in humans at toxic doses is thinner. If someone has been taking very large amounts of aspirin daily for weeks or months, especially an older adult with some pre-existing hearing loss, a doctor should be involved in evaluating recovery.

How Much Aspirin Does It Take?

Tinnitus is not a risk at low, standard doses. A daily baby aspirin (81 mg) for cardiovascular protection sits well below the threshold. Tinnitus from aspirin is generally associated with high therapeutic or supratherapeutic doses, the kind historically used for inflammatory conditions like rheumatic fever or severe arthritis, where daily intake might reach several grams. Most case reports and animal studies use doses that produce blood salicylate levels of 20 to 40 mg/dL or higher. At those concentrations, salicylate builds up to the point where it saturates enough prestin binding sites and NMDA receptors to produce audible symptoms.

The dose-response relationship is steep enough that tinnitus is actually used clinically as a rough indicator of salicylate toxicity. If a patient on high-dose aspirin therapy starts hearing ringing, it signals that blood levels are approaching the upper limit. This has historically been called the “salicylate threshold” for ototoxicity. Individual sensitivity varies, though. People with pre-existing hearing loss, older adults, and those with kidney impairment (who clear salicylate more slowly) may develop tinnitus at lower doses than younger, healthy adults.

Do Other Painkillers Cause Tinnitus Too?

Aspirin is the most studied culprit, but it is not the only analgesic linked to tinnitus. A large longitudinal study tracking tens of thousands of women found that frequent use of non-aspirin NSAIDs (like ibuprofen and naproxen) and acetaminophen was also associated with a higher risk of developing persistent tinnitus. Women who used non-aspirin NSAIDs four to five days per week had a roughly 17% greater risk compared with infrequent users.

The mechanisms are not identical across drug classes. Ibuprofen and naproxen share some of aspirin’s cyclooxygenase-inhibiting chemistry but may not bind to prestin in the same way. Acetaminophen works through entirely different pathways, yet the epidemiological link to tinnitus persists. Researchers suspect that each drug may affect different parts of the auditory system or different molecular targets, converging on the same symptom through distinct routes. What this means practically is that switching from aspirin to another over-the-counter painkiller does not guarantee you will avoid tinnitus if you are using high doses frequently.

Why Researchers Use Aspirin to Study Tinnitus

The reversibility of aspirin-induced tinnitus is actually what makes it so valuable to science. Tinnitus from noise damage or aging is permanent and variable, which makes it hard to study in a controlled way. Salicylate gives researchers a reliable on/off switch: administer the drug and tinnitus appears; withdraw it and the tinnitus goes away. This allows controlled experiments in animal models that would be impossible with permanent tinnitus.

Animal models of salicylate-induced tinnitus have been instrumental in mapping out the neural pathways involved and testing potential treatments. Behavioral tests measure tinnitus by exploiting the fact that animals with tinnitus have difficulty detecting brief silences in background noise, because the phantom sound “fills in” the gap. One study using this approach showed that salicylate produced temporary tinnitus while noise trauma produced permanent tinnitus, giving researchers a way to compare the two conditions side by side.

Much of what we know about tinnitus mechanisms in general, including the central gain model and the role of GABA reduction, was first worked out using salicylate as the experimental tool. The findings then informed research on noise-induced and age-related tinnitus, conditions that affect far more people but are harder to study mechanistically.

Protecting the Inner Ear During High-Dose Therapy

For the relatively small number of people who still require high-dose aspirin or salicylate therapy (certain autoimmune and inflammatory conditions), the question of whether anything can buffer the ears has drawn some research interest. Animal studies on antioxidant therapy have shown promise in preventing hearing damage from various ototoxic exposures, including noise and certain drugs. Antioxidants appear to work best when given before or during the insult, not after the damage is underway.

Whether antioxidant supplements meaningfully protect against salicylate-specific tinnitus in humans remains unproven. The practical advice for now is simpler: if you notice ringing in your ears while taking aspirin at any dose, tell your doctor. The symptom is a built-in warning system. In most cases, a dose reduction or switch to a different drug resolves it. And for the many people taking a daily low-dose aspirin for heart protection, tinnitus from that regimen alone is unlikely. The phenomenon is almost always about dose, and at 81 mg per day, you are well below the danger zone.